Pharmacogenetic Testing Education Effect on Psychiatric Prescriber Genetic Testing Practices

Abstract

Antidepressant prescribing generally relies on theoretical inference and presenting symptoms with only one-third of patients with major depressive disorder (MDD)reaching full remission in the first trial. Repeated medication trials prolong treatment increasing the risk of suicide, and have a deleterious effect on readiness. Pharmacogenetic testing can provide insights to guide antidepressant prescription decisions in medication selection and dosage to reduce the overall, but pharmacogenetic testing is an underutilized modality

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 12, 2019
Accession Number
AD1182822

Entities

People

  • Dennis Flynn
  • Jasmine Peterson

Organizations

  • Uniformed Services University of the Health Sciences

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Antidepressants
  • Anxiety Disorders
  • Department Of Defense
  • Depression
  • Genetic Engineering
  • Health Care
  • Health Services
  • Medical Personnel
  • Mental Disorders
  • Patient Care
  • Personalized Medicine
  • Psychiatry
  • Students
  • Therapy
  • Traumatic Stress Disorder
  • United States Government

Fields of Study

  • Medicine
  • Psychology

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Systems Analysis and Design
  • Virology (or Medical Virology).

Technology Areas

  • AI & ML
  • AI & ML - Bayesian Inference
  • AI & ML - DoD AI Strategy
  • Biotechnology